Andrew K. Chan

Andrew K. Chan appears in our data through filings on Cellular Biomedicine Group, Inc. shares, published by SEC (Form 4). Between 19 January 2016 and 21 January 2016, the trades on record add up to 4 filings.

Every open-market trade on record is a sale: 2 sales. The amount is not disclosed for 2 filings. The rest of the record consists of 2 option exercises.

The latest filing, published on 21 January 2016, reports an option exercise in Cellular Biomedicine Group, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.